JP2014506602A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506602A5 JP2014506602A5 JP2013555597A JP2013555597A JP2014506602A5 JP 2014506602 A5 JP2014506602 A5 JP 2014506602A5 JP 2013555597 A JP2013555597 A JP 2013555597A JP 2013555597 A JP2013555597 A JP 2013555597A JP 2014506602 A5 JP2014506602 A5 JP 2014506602A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- crystalline form
- pentalene
- diaza
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161446732P | 2011-02-25 | 2011-02-25 | |
| US61/446,732 | 2011-02-25 | ||
| US201161448542P | 2011-03-02 | 2011-03-02 | |
| US61/448,542 | 2011-03-02 | ||
| PCT/US2012/026506 WO2012116276A1 (en) | 2011-02-25 | 2012-02-24 | Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506602A JP2014506602A (ja) | 2014-03-17 |
| JP2014506602A5 true JP2014506602A5 (enExample) | 2015-04-16 |
| JP5945554B2 JP5945554B2 (ja) | 2016-07-05 |
Family
ID=45841624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013555597A Expired - Fee Related JP5945554B2 (ja) | 2011-02-25 | 2012-02-24 | 縮合型アザ環の結晶形およびその調製プロセス（カンナビノイド受容体モジュレーター） |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US9458136B2 (enExample) |
| EP (3) | EP4166552B1 (enExample) |
| JP (1) | JP5945554B2 (enExample) |
| KR (1) | KR102036932B1 (enExample) |
| CN (1) | CN103608343B (enExample) |
| AU (1) | AU2012222146B2 (enExample) |
| BR (1) | BR112013021549B1 (enExample) |
| CA (1) | CA2827057C (enExample) |
| CL (1) | CL2013002436A1 (enExample) |
| CO (1) | CO6852066A2 (enExample) |
| DK (1) | DK3395812T3 (enExample) |
| EA (1) | EA035989B1 (enExample) |
| ES (1) | ES2932441T3 (enExample) |
| IL (1) | IL227782A (enExample) |
| MX (1) | MX346533B (enExample) |
| MY (1) | MY165767A (enExample) |
| PH (1) | PH12013501726A1 (enExample) |
| SG (1) | SG192817A1 (enExample) |
| WO (1) | WO2012116276A1 (enExample) |
| ZA (1) | ZA201306402B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ598288A (en) | 2009-08-28 | 2014-02-28 | Arena Pharm Inc | Cannabinoid receptor modulators |
| US9597340B2 (en) | 2011-02-25 | 2017-03-21 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| ES2929977T3 (es) | 2011-02-25 | 2022-12-05 | Arena Pharm Inc | Moduladores del receptor cannabinoide |
| CA2827057C (en) | 2011-02-25 | 2022-06-07 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of condensed azacycles (cannabinoid receptor modulators) |
| WO2016085941A1 (en) * | 2014-11-25 | 2016-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of cannabinoid receptor modulators |
| UA124626C2 (uk) * | 2016-04-10 | 2021-10-20 | Арена Фармасьютікалз, Інк. | СПОСОБИ ЛІКУВАННЯ СЕЛЕКТИВНИМИ АГОНІСТАМИ РЕЦЕПТОРА СВ<sub>2</sub> |
| KR20200005614A (ko) | 2017-05-08 | 2020-01-15 | 아레나 파마슈티칼스, 인크. | 내장 통증의 치료를 위한 화합물 및 방법 |
| WO2018208847A1 (en) | 2017-05-08 | 2018-11-15 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of pain from inflammatory bowel disease |
| CN114391011A (zh) * | 2019-09-12 | 2022-04-22 | 四川海思科制药有限公司 | 一种六氢化苯并吡唑衍生物及其制备 |
| WO2023059610A1 (en) | 2021-10-05 | 2023-04-13 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of cannabinoid receptor modulators |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3964478B2 (ja) | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
| IL145922A0 (en) | 1999-04-28 | 2002-07-25 | Aventis Pharma Gmbh | Di-aryl acid derivatives as ppar receptor ligands |
| US20040259936A1 (en) | 2001-12-07 | 2004-12-23 | Nagarkatti Leonard C | Treatment of neoplasia |
| SE0300010D0 (sv) | 2003-01-07 | 2003-01-07 | Astrazeneca Ab | Novel Compounds |
| WO2005123677A1 (en) | 2004-06-16 | 2005-12-29 | Actelion Pharmaceuticals Ltd | 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents |
| WO2006025069A2 (en) | 2004-07-12 | 2006-03-09 | Cadila Healthcare Limited | Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| FR2875230A1 (fr) * | 2004-09-13 | 2006-03-17 | Sanofi Aventis Sa | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
| DE102004054666A1 (de) | 2004-11-12 | 2006-05-18 | Bayer Cropscience Gmbh | Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| PE20060949A1 (es) | 2004-12-23 | 2006-10-11 | Arena Pharm Inc | Derivados fusionados de pirazol como agonistas del receptor de niacina |
| CN101238107A (zh) * | 2005-06-02 | 2008-08-06 | 格兰马克药品股份有限公司 | 新的大麻素受体配体，含有该配体的药物组合物及其制备方法 |
| EP1902034B1 (en) * | 2005-06-02 | 2011-03-30 | Glenmark Pharmaceuticals S.A. | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| EA200970080A1 (ru) | 2006-07-04 | 2009-06-30 | Янссен Фармацевтика Нв | Бензимидазольные агонисты каннабиноидов, содержащие замещенную гетероциклическую группу |
| JP5030114B2 (ja) | 2006-09-25 | 2012-09-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体をモジュレートする化合物 |
| US8481574B2 (en) | 2006-10-12 | 2013-07-09 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
| US7928103B2 (en) | 2006-10-17 | 2011-04-19 | Boehringer Ingelheim International Gmbh | Compounds which modulate the CB2 receptor |
| CA2668491A1 (en) | 2006-11-03 | 2008-05-08 | Glenmark Pharmaceuticals S.A. | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| WO2008064054A2 (en) | 2006-11-21 | 2008-05-29 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| WO2008079316A1 (en) | 2006-12-20 | 2008-07-03 | Cara Therapeutics, Inc. | Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof |
| WO2008085302A1 (en) | 2006-12-20 | 2008-07-17 | Merck & Co., Inc. | Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| US20080214537A1 (en) | 2007-03-02 | 2008-09-04 | Cara Therapeutics, Inc. | Bridged phenanthridines |
| JP5185924B2 (ja) | 2007-03-16 | 2013-04-17 | 京セラ株式会社 | 誘電体磁器およびコンデンサ |
| ES2548764T3 (es) | 2007-03-30 | 2015-10-20 | Janssen Pharmaceutica N.V. | Agonistas de cannabinoides de bencimidazol |
| US20090209536A1 (en) | 2007-06-17 | 2009-08-20 | Kalypsys, Inc. | Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| BRPI0812504B8 (pt) | 2007-06-21 | 2021-05-25 | Cara Therapeutics Inc | composto para profilaxia ou tratamento de doença ou condição associada a receptor de canabinoides em sujeito mamífero |
| US8338623B2 (en) | 2007-07-09 | 2012-12-25 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
| US7943658B2 (en) | 2007-07-23 | 2011-05-17 | Bristol-Myers Squibb Company | Indole indane amide compounds useful as CB2 agonists and method |
| WO2009025785A2 (en) | 2007-08-21 | 2009-02-26 | Merck & Co., Inc. | Cb2 receptor ligands for the treatment of pain |
| UA104010C2 (en) | 2008-12-18 | 2013-12-25 | Эли Лилли Энд Компани | Purine compounds |
| WO2010088050A2 (en) | 2009-01-28 | 2010-08-05 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
| US7741350B1 (en) * | 2009-01-28 | 2010-06-22 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
| NZ598288A (en) * | 2009-08-28 | 2014-02-28 | Arena Pharm Inc | Cannabinoid receptor modulators |
| CA2827057C (en) | 2011-02-25 | 2022-06-07 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of condensed azacycles (cannabinoid receptor modulators) |
| ES2929977T3 (es) * | 2011-02-25 | 2022-12-05 | Arena Pharm Inc | Moduladores del receptor cannabinoide |
| US9597340B2 (en) | 2011-02-25 | 2017-03-21 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| WO2012116278A1 (en) | 2011-02-25 | 2012-08-30 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
-
2012
- 2012-02-24 CA CA2827057A patent/CA2827057C/en active Active
- 2012-02-24 BR BR112013021549-6A patent/BR112013021549B1/pt not_active IP Right Cessation
- 2012-02-24 MX MX2013009760A patent/MX346533B/es active IP Right Grant
- 2012-02-24 JP JP2013555597A patent/JP5945554B2/ja not_active Expired - Fee Related
- 2012-02-24 AU AU2012222146A patent/AU2012222146B2/en not_active Ceased
- 2012-02-24 DK DK18164225.7T patent/DK3395812T3/da active
- 2012-02-24 CN CN201280020512.3A patent/CN103608343B/zh not_active Expired - Fee Related
- 2012-02-24 EP EP22197435.5A patent/EP4166552B1/en active Active
- 2012-02-24 MY MYPI2013003122A patent/MY165767A/en unknown
- 2012-02-24 PH PH1/2013/501726A patent/PH12013501726A1/en unknown
- 2012-02-24 KR KR1020137025057A patent/KR102036932B1/ko not_active Expired - Fee Related
- 2012-02-24 US US14/001,133 patent/US9458136B2/en active Active
- 2012-02-24 WO PCT/US2012/026506 patent/WO2012116276A1/en not_active Ceased
- 2012-02-24 ES ES18164225T patent/ES2932441T3/es active Active
- 2012-02-24 SG SG2013062427A patent/SG192817A1/en unknown
- 2012-02-24 EA EA201391233A patent/EA035989B1/ru not_active IP Right Cessation
- 2012-02-24 EP EP18164225.7A patent/EP3395812B8/en active Active
- 2012-02-24 EP EP12709201.3A patent/EP2678330A1/en not_active Withdrawn
-
2013
- 2013-08-04 IL IL227782A patent/IL227782A/en active IP Right Grant
- 2013-08-23 CL CL2013002436A patent/CL2013002436A1/es unknown
- 2013-08-23 ZA ZA2013/06402A patent/ZA201306402B/en unknown
- 2013-09-10 CO CO13214674A patent/CO6852066A2/es active IP Right Grant
-
2016
- 2016-08-26 US US15/248,300 patent/US10183930B2/en active Active
-
2018
- 2018-12-10 US US16/214,388 patent/US10981895B2/en active Active
-
2021
- 2021-03-16 US US17/202,946 patent/US11560369B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100369894C (zh) | 氧化氮合酶抑制剂磷酸盐 | |
| DE60115227T2 (de) | Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga | |
| JP2022516575A (ja) | ケタミン誘導体およびその組成物 | |
| US7968581B2 (en) | Imidazolidine compounds as androgen receptor modulators | |
| AU2017254523A1 (en) | Compounds and compositions for treating conditions associated with NLRP activity | |
| JP7241856B2 (ja) | ビス第四級アンモニウム化合物及びその製造方法と使用 | |
| CN109071509A (zh) | 作为ROR-γ的调节剂的苯并咪唑衍生物 | |
| EA025529B1 (ru) | Циклопропанаминовое соединение | |
| JP5945554B2 (ja) | 縮合型アザ環の結晶形およびその調製プロセス（カンナビノイド受容体モジュレーター） | |
| JP7159440B2 (ja) | ジカチオン化合物及びその製造方法と使用 | |
| MX2022006990A (es) | Forma cristalina de un derivado del acido 7h-benzo[7]anuleno-2-car boxilico. | |
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| SK16702002A3 (sk) | Polymorfná forma V 5-chlór-3-(4-metánsulfonylfenyl)-6'-metyl- [2,3']bipyridinylu, spôsob jej výroby, farmaceutický prostriedok s jej obsahom a jej použitie | |
| SA99191012B1 (ar) | مشتقات حمض فينيل أمينو ألكيل كربوكسيلي phenyl amino alkyl carboxylic وتركيبات طبية تشتمل عليها | |
| CN104341351A (zh) | 一种新型的二芳基硫代乙内酰脲衍生物及其应用 | |
| JP6275644B2 (ja) | Ｎ−［２−（｛２−［（２Ｓ）−２−シアノピロリジン−１−イル］−２−オキソエチル｝アミノ）−２−メチルプロピル］−２−メチルピラゾロ［１，５−ａ］ピリミジン−６−カルボキサミドの結晶 | |
| CS227012B2 (en) | Method of preparing 2-amino-3-benzoyl-phenylacetamide | |
| JP2026511124A (ja) | 置換チオフェン縮合シクロヘキサノン誘導体、それを含む組成物及び医薬品としてのそれらの使用 | |
| WO2018085263A1 (en) | Compounds for treatment of neurodegenerative diseases | |
| CN106478603B (zh) | 尼洛替尼盐酸盐的新晶型及其制备方法和医药用途 | |
| CN104529833B (zh) | 取代的环丁烷羧酸类化合物及其用途 | |
| CN104496918B (zh) | 吡嗪衍生物及其用途 | |
| WO2025032195A1 (en) | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate | |
| JP2018526387A (ja) | 疼痛のための治療化合物及びその合成 | |
| NZ750729A (en) | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |